You can buy or sell CureVac and other stocks, options, and ETFs commission-free!
CureVac N.V. Ordinary Shares, also called CureVac, is a clinical-stage biopharmaceutical Company developing tumour immunotherapy. Read More It offers RNA optimization that encode functional proteins that replace defective or missing proteins using the cell's intrinsic translation machinery. The company was founded by Ingmar Hoerr and Florian von der Mülbe in 2000 and is headquartered in Tübingen, Germany. The listed name for CVAC is CureVac N.V. Ordinary Shares.
Tubingen, Baden Wuerttemberg
52 Week High
52 Week Low